🇺🇸 FDA
Patent

US 11026898

Eutectic formulations of cyclobenzaprine hydrochloride

granted A61KA61K31/135A61K9/1623

Quick answer

US patent 11026898 (Eutectic formulations of cyclobenzaprine hydrochloride) held by TONIX PHARMA LIMITED expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TONIX PHARMA LIMITED
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/135, A61K9/1623, A61K9/2018, A61P